Silvant Capital Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,305
| Closed | -$78K | – | 298 |
|
|
2022
Q3 | $78K | Sell |
2,305
-1,907
| -45% | -$64.5K | 0.01% | 273 |
|
|
2022
Q2 | $40K | Hold |
4,212
| – | – | 0.01% | 284 |
|
|
2022
Q1 | $60K | Hold |
4,212
| – | – | 0.01% | 268 |
|
|
2021
Q4 | $89K | Sell |
4,212
-270
| -6% | -$5.71K | 0.02% | 236 |
|
|
2021
Q3 | $100K | Hold |
4,482
| – | – | 0.02% | 225 |
|
|
2021
Q2 | $111K | Hold |
4,482
| – | – | 0.02% | 225 |
|
|
2021
Q1 | $130K | Hold |
4,482
| – | – | 0.02% | 213 |
|
|
2020
Q4 | $116K | Hold |
4,482
| – | – | 0.02% | 217 |
|
|
2020
Q3 | $138K | Buy |
4,482
+1,684
| +60% | +$51.9K | 0.03% | 199 |
|
|
2020
Q2 | $70K | Buy |
+2,798
| New | +$70K | 0.01% | 234 |
|